GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXA) » Definitions » Accounts Receivable

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Accounts Receivable : $0.00 Mil (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Lux Health Tech Acquisition's accounts receivables for the quarter that ended in Jun. 2022 was $0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Lux Health Tech Acquisition's Net-Net Working Capital per share for the quarter that ended in Jun. 2022 was $-0.37.


Lux Health Tech Acquisition Accounts Receivable Historical Data

The historical data trend for Lux Health Tech Acquisition's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition Accounts Receivable Chart

Lux Health Tech Acquisition Annual Data
Trend Dec20 Dec21
Accounts Receivable
- -

Lux Health Tech Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Accounts Receivable Get a 7-Day Free Trial - - - - -

Lux Health Tech Acquisition Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Lux Health Tech Acquisition Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Lux Health Tech Acquisition's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Lux Health Tech Acquisition's accounts receivable are only considered to be worth 75% of book value:

Lux Health Tech Acquisition's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2022 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.025+0.75 * 0+0.5 * 0-15.888
-0-0)/43.125
=-0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Lux Health Tech Acquisition Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
920 Broadway, 11th Floor, New York, NY, USA, 10010
Lux Health Tech Acquisition Corp is a blank check company.
Executives
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo director, officer: Chief Executive Officer 1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert director, 10 percent owner C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh director C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough officer: CFO and Treasurer C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines